PT2794665T - Non anti-coagulative glycosaminoglycans comprising repeating disaccharide unit and their medical use - Google Patents

Non anti-coagulative glycosaminoglycans comprising repeating disaccharide unit and their medical use

Info

Publication number
PT2794665T
PT2794665T PT128588092T PT12858809T PT2794665T PT 2794665 T PT2794665 T PT 2794665T PT 128588092 T PT128588092 T PT 128588092T PT 12858809 T PT12858809 T PT 12858809T PT 2794665 T PT2794665 T PT 2794665T
Authority
PT
Portugal
Prior art keywords
coagulative
glycosaminoglycans
medical use
disaccharide unit
repeating disaccharide
Prior art date
Application number
PT128588092T
Other languages
Portuguese (pt)
Inventor
Olov Eriksson Per
Peter Ekre Hans
Lindahl Ulf
Holmer Erik
Original Assignee
Dilafor Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48668970&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2794665(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dilafor Ab filed Critical Dilafor Ab
Publication of PT2794665T publication Critical patent/PT2794665T/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
PT128588092T 2011-12-19 2012-12-19 Non anti-coagulative glycosaminoglycans comprising repeating disaccharide unit and their medical use PT2794665T (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161577223P 2011-12-19 2011-12-19

Publications (1)

Publication Number Publication Date
PT2794665T true PT2794665T (en) 2018-01-24

Family

ID=48668970

Family Applications (1)

Application Number Title Priority Date Filing Date
PT128588092T PT2794665T (en) 2011-12-19 2012-12-19 Non anti-coagulative glycosaminoglycans comprising repeating disaccharide unit and their medical use

Country Status (28)

Country Link
US (1) US9475888B2 (en)
EP (1) EP2794665B1 (en)
JP (2) JP6543467B2 (en)
KR (1) KR102135485B1 (en)
CN (1) CN104144950B (en)
AU (1) AU2012354229B2 (en)
BR (1) BR112014014454B1 (en)
CA (1) CA2856492C (en)
CL (1) CL2014001651A1 (en)
CO (1) CO7061069A2 (en)
CY (1) CY1119899T1 (en)
DK (1) DK2794665T3 (en)
ES (1) ES2656613T3 (en)
HK (1) HK1202883A1 (en)
HR (1) HRP20180124T1 (en)
HU (1) HUE036523T2 (en)
IL (1) IL232905A (en)
LT (1) LT2794665T (en)
ME (1) ME02994B (en)
MX (1) MX351104B (en)
NO (1) NO2904345T3 (en)
PL (1) PL2794665T3 (en)
PT (1) PT2794665T (en)
RS (1) RS56874B1 (en)
RU (1) RU2617764C2 (en)
SI (1) SI2794665T1 (en)
WO (1) WO2013095279A1 (en)
ZA (1) ZA201403640B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013095215A1 (en) 2011-12-19 2013-06-27 Dilaforette Ab Low anticoagulant heparins
CN104244957B (en) * 2012-03-26 2017-11-17 迪乐方有限责任公司 The method stopped for treating childbirth
UA117908C2 (en) * 2012-03-26 2018-10-25 Ділафор Аб Combination treatment comprising sulphated glycosaminoglycans for inducing labor
AU2013260209A1 (en) * 2012-05-08 2014-11-20 Dilafor Ab Treatment of postpartum haemorrhage with chemically modified heparin or heparan sulphate and a uterotonic agent
GB2515315A (en) * 2013-06-19 2014-12-24 Dilafor Ab New Processes
CN103788222B (en) * 2014-01-08 2016-08-31 中国科学院昆明植物研究所 Substituted oligomeric glycosaminoglycans of Fuc3S4S and preparation method thereof
BR112016025443A2 (en) * 2014-04-30 2017-12-12 Agency Science Tech & Res heparan sulfates
CN108424474B (en) * 2017-02-15 2023-07-25 清华大学 Deanticoagulated heparin derivatives and their use in the treatment of inflammatory bowel disease
BR112022014456A2 (en) 2020-02-17 2022-09-13 Dilafor Ab TAFOXIPARIN FOR THE TREATMENT OF PREECLAMPSIA
US20230355658A1 (en) 2022-05-03 2023-11-09 Dilafor Ab Medical use of tafoxiparin
EP4272749A1 (en) 2022-05-03 2023-11-08 Dilafor AB New medical use of tafoxiparin

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1136620A (en) * 1979-01-08 1982-11-30 Ulf P.F. Lindahl Heparin fragments having selective anticoagulation activity
JPS63246396A (en) * 1987-03-31 1988-10-13 Shiseido Co Ltd Monoclonal antibody
FR2614026B1 (en) * 1987-04-16 1992-04-17 Sanofi Sa LOW MOLECULAR WEIGHT HEPARINS WITH REGULAR STRUCTURE, THEIR PREPARATION AND THEIR BIOLOGICAL APPLICATIONS
SE9002550D0 (en) 1990-08-01 1990-08-01 Kabivitrum Ab heparin fragments
SE9003181D0 (en) 1990-10-04 1990-10-04 Kabivitrum Ab USE OF HEPARIN FRACTION
US5280016A (en) 1991-03-29 1994-01-18 Glycomed Incorporated Non-anticoagulant heparin derivatives
US5250519A (en) 1991-03-29 1993-10-05 Glycomed Incorporated Non-anticoagulant heparin derivatives
JPH0532703A (en) * 1991-07-26 1993-02-09 Terumo Corp Production of low-molecular weight heparin derivative
WO1994008595A1 (en) * 1992-10-13 1994-04-28 Virginia Commonwealth University Use of non-anticoagulant heparin for treating ischemia/reperfusion injury
US5527785A (en) 1993-05-14 1996-06-18 The Regents Of The University Of California Selectin receptor modulating compositions
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
DE69623840D1 (en) * 1995-03-31 2002-10-31 Hamilton Civic Hospitals Res Composition for inhibiting the development of thrombosis
US5993810A (en) 1996-03-15 1999-11-30 Lebovitz; Shamir Israel Method of softening or ripening the cervix of a female mammal using collagenase
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
CA2240328A1 (en) 1996-10-15 1998-04-23 Toray Industries, Inc. Cervical canal maturing agent
GB9711443D0 (en) * 1997-06-03 1997-07-30 Leo Pharm Prod Ltd Chemical suppositions
WO1999026984A1 (en) * 1997-11-20 1999-06-03 Ikuo Yamashina Low-molecular heparin modification and remedy for skin ulcer
US6596705B1 (en) 1998-02-09 2003-07-22 The Regents Of The University Of California Inhibition of L-selectin and P-selection mediated binding using heparin
DE69931038T2 (en) 1998-02-26 2006-11-23 Seikagaku Corp. NEW POLYSACCHARIDE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICAL COMPOSITIONS THEREOF CONTAINING THEM AS AN ACTIVE INGREDIENT
US6028061A (en) 1998-06-18 2000-02-22 Children's Medical Center Corp Angiogenesis inhibitors and use thereof
KR20010030803A (en) * 1998-07-31 2001-04-16 야마야 와따루 Novel glycosaminoglycan and drug compositions containing the same
CA2341668A1 (en) * 1998-08-26 2000-03-09 The Collaborative Group, Ltd. Receptor for underivatized, aqueous soluble beta-(1,3)-glucan
PL353335A1 (en) * 1999-06-30 2003-11-17 Hamilton Civic Hospitals Research Development, Inc. Heparin compositions that inhibit clot associated coagulation factors
JP4897991B2 (en) * 1999-07-23 2012-03-14 ラボラトリオス ファルマセウティコス ロビ ソシエダッド アノニマ Ultra low molecular weight heparin composition
IT1316986B1 (en) 2000-01-25 2003-05-26 Sigma Tau Ind Farmaceuti GLYCOSAMINOGLICAN DERIVATIVES PARTIALLY DESULPHATED NONANTICOAGULANTS WITH ANTIANGIOGENIC ACTIVITY.
JP4585072B2 (en) * 2000-02-29 2010-11-24 扶桑薬品工業株式会社 Heparin depolymerization method, depolymerized heparin, derivatives thereof and pharmaceutical composition
EP1319183B1 (en) * 2000-09-12 2009-03-25 Massachusetts Institute Of Technology Methods and products related to low molecular weight heparin
SE521676C2 (en) * 2002-01-02 2003-11-25 Dilafor Ab Use of glycosaminoglycans for the prevention and treatment of pain in full-term pregnancy
AU2003230985A1 (en) 2002-04-18 2003-11-03 Stephen H. Embury Method and composition for preventing pain in sickle cell patients
US8071569B2 (en) 2002-09-20 2011-12-06 Mousa Shaker A Oxidized heparin fractions and their use in inhibiting angiogenesis
JP2005106694A (en) * 2003-09-30 2005-04-21 Mochida Pharmaceut Co Ltd Early detection of blood poisoning and evaluation on seriousness
EP1582531A1 (en) 2004-03-24 2005-10-05 Aventis Pharma S.A. Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
US20060040896A1 (en) * 2004-08-18 2006-02-23 Paringenix, Inc. Method and medicament for anticoagulation using a sulfated polysaccharide with enhanced anti-inflammatory activity
US7741311B2 (en) 2005-01-03 2010-06-22 Shaker Mousa Composition and method for treating occlusive vascular diseases, nerve regeneration, and wound healing
US20080214480A1 (en) 2005-07-22 2008-09-04 Trf Pharma, Inc. Method for Treating Sickle Cell Disease and Sickle Cell Disease Sequalae
JP2009507209A (en) * 2005-07-22 2009-02-19 ザ レジェンツ オブ ザ ユニヴァースティ オブ カリフォルニア Heparin composition and selectin inhibition
JP5308328B2 (en) * 2006-04-04 2013-10-09 シングレックス，インコーポレイテッド Sensitive system and method for the analysis of troponin
CN101495517B (en) * 2006-05-25 2012-10-10 莫曼塔医药品有限公司 Low molecular weight heparin composition and uses thereof
WO2009007224A1 (en) * 2007-07-10 2009-01-15 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Low molecular weight heparin derivatives having neuroprotective activity
US9351992B2 (en) 2007-11-02 2016-05-31 Momenta Pharmaceuticals, Inc. Non-anticoagulant polysaccharide compositions
CN101842392B (en) * 2007-11-02 2014-08-27 动量制药公司 Non-anticoagulant polysaccharide compositions
US8569262B2 (en) 2007-11-02 2013-10-29 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
US8592393B2 (en) * 2007-11-02 2013-11-26 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
US8445436B2 (en) 2007-12-03 2013-05-21 Florida State University Research Foundation, Inc. Oxytocin and melatonin compositions and associated methods for inducing labor
AU2009231634B2 (en) 2008-04-04 2014-05-15 University Of Utah Research Foundation Alkylated semi-synthetic glycosaminoglycosan ethers, and methods for making and using thereof
US8680200B2 (en) * 2009-03-27 2014-03-25 Actamax Surgical Materials Llc Polyglycerol aldehydes
ES2458818T3 (en) 2009-04-16 2014-05-07 Momenta Pharmaceuticals, Inc. Methods to evaluate the activity of a polysaccharide composition
US20120108538A1 (en) 2009-06-30 2012-05-03 James Beeson Sulfated polysaccharides having antiplasmodial activity and methods and products for identifying antiplasmodial activity
EA201290069A1 (en) * 2009-07-31 2012-07-30 Байер Хелскер Ллс MODIFIED POLYPEPTIDES OF FACTOR IX AND THEIR APPLICATION
DK2515957T3 (en) * 2009-12-22 2015-11-09 Lifebond Ltd CHANGE OF ENZYMATIC CIRCULATORS FOR MANAGEMENT OF CHARACTERISTICS BY CIRCUIT MATRIX
WO2013095215A1 (en) 2011-12-19 2013-06-27 Dilaforette Ab Low anticoagulant heparins
CN104244957B (en) 2012-03-26 2017-11-17 迪乐方有限责任公司 The method stopped for treating childbirth
UA117908C2 (en) 2012-03-26 2018-10-25 Ділафор Аб Combination treatment comprising sulphated glycosaminoglycans for inducing labor

Also Published As

Publication number Publication date
AU2012354229B2 (en) 2016-12-01
RU2014129816A (en) 2016-02-20
BR112014014454A2 (en) 2017-06-13
IL232905A (en) 2017-02-28
CN104144950A (en) 2014-11-12
US20150011505A1 (en) 2015-01-08
BR112014014454B1 (en) 2021-03-09
CA2856492C (en) 2017-01-10
CO7061069A2 (en) 2014-09-19
JP2018111825A (en) 2018-07-19
WO2013095279A1 (en) 2013-06-27
HUE036523T2 (en) 2018-07-30
ME02994B (en) 2018-10-20
RU2617764C2 (en) 2017-04-26
CY1119899T1 (en) 2018-06-27
NO2904345T3 (en) 2018-07-21
ES2656613T3 (en) 2018-02-27
SI2794665T1 (en) 2018-03-30
JP6543467B2 (en) 2019-07-10
EP2794665B1 (en) 2017-11-22
HRP20180124T1 (en) 2018-02-23
HK1202883A1 (en) 2015-10-09
ZA201403640B (en) 2017-06-28
EP2794665A4 (en) 2015-08-26
CA2856492A1 (en) 2013-06-27
LT2794665T (en) 2017-12-27
PL2794665T3 (en) 2018-04-30
AU2012354229A1 (en) 2014-06-05
JP2015500388A (en) 2015-01-05
CN104144950B (en) 2017-09-05
EP2794665A1 (en) 2014-10-29
MX2014007122A (en) 2015-03-05
DK2794665T3 (en) 2018-01-29
MX351104B (en) 2017-10-02
CL2014001651A1 (en) 2014-10-10
US9475888B2 (en) 2016-10-25
RS56874B1 (en) 2018-04-30
KR102135485B1 (en) 2020-07-17
IL232905A0 (en) 2014-07-31
KR20140113652A (en) 2014-09-24

Similar Documents

Publication Publication Date Title
HK1202883A1 (en) Non anti-coagulative glycosaminoglycans comprising repeating disaccharide unit and their medical use
EP2797512A4 (en) Image-overlay medical evaluation devices and techniques
IL234628A0 (en) Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments
EP2614480A4 (en) Medical scoring systems and methods
HK1160450A1 (en) Sulfonylated tetrahydroazolopyrazines and their use as medicinal products
GB201010193D0 (en) Medicinal use
EP2563426A4 (en) High shear application in medical therapy
EP2819611A4 (en) Dental products and procedures
EP2740728A4 (en) Uracil derivative and use thereof for medical purposes
EP2586448A4 (en) Skin properties improving agent for oral administration
EP2718283A4 (en) Indazole- and pyrrolopyridine-derivative and pharmaceutical use thereof
IL228433A0 (en) Pyridopyrazine derivatives and their use
IL232824A0 (en) Mmp-targeted therapeutic and/or diagnostic nanocarriers
HK1205698A1 (en) Chondroitin for use in medicine
HK1198939A1 (en) Pharmaceutical preparation comprising brexpiprazole and substituted beta - cyclodextrin brexpiprazole -
HK1196535A1 (en) Salt and medical use
EP2730230A4 (en) Ultrasound unit and ultrasound endoscope
EP2736519A4 (en) Alkaline compositions and their dental and medical use
EP2676595A4 (en) Endoscope adapter and endoscope
IL232239A0 (en) Medical use
EP2893881A4 (en) Ultrasound unit and ultrasound endoscope
HK1198587A1 (en) Isothiazolopyridine-2-carboxamides and their use as pharmaceuticals -2-
EP2859852A4 (en) Ultrasonic unit and ultrasonic endoscope
ZA201304369B (en) Use of glycosaminoglycan lipote esters in the trichology field
GB201112578D0 (en) Pharmaceutical preparation and use